Literature DB >> 32130926

Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction.

Sebastian Cremer1, Maximilian J Schloss1, Claudio Vinegoni1, Brody H Foy2, Shuang Zhang1, David Rohde1, Maarten Hulsmans1, Paolo Fumene Feruglio3, Stephen Schmidt1, Greg Wojtkiewicz1, John M Higgins2, Ralph Weissleder1, Filip K Swirski1, Matthias Nahrendorf4.   

Abstract

BACKGROUND: Recurrent myocardial infarction (MI) is common in patients with coronary artery disease and is associated with high mortality. Long-term reprogramming of myeloid progenitors occurs in response to inflammatory stimuli and alters the organism's response to secondary inflammatory challenges.
OBJECTIVES: This study examined the effect of recurrent MI on bone marrow response and cardiac inflammation.
METHODS: The investigators developed a surgical mouse model in which 2 subsequent MIs affected different left ventricular regions in the same mouse. Recurrent MI was induced by ligating the left circumflex artery followed by the left anterior descending coronary artery branch. The study characterized the resulting ischemia by whole-heart fluorescent coronary angiography after optical organ clearing and by cardiac magnetic resonance imaging.
RESULTS: A first MI-induced bone marrow "memory" via a circulating signal, reducing hematopoietic maintenance factor expression in bone marrow macrophages. This dampened the organism's reaction to subsequent events. Despite a similar extent of injury according to troponin levels, recurrent MI caused reduced emergency hematopoiesis and less leukocytosis than a first MI. Consequently, fewer leukocytes migrated to the ischemic myocardium. The hematopoietic response to lipopolysaccharide was also mitigated after a previous MI. The increase of white blood count in 28 patients was lower after recurrent MI compared with their first MI.
CONCLUSIONS: The data suggested that hematopoietic and innate immune responses are shaped by a preceding MI.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone marrow; emergency hematopoiesis; immune memory; inflammation; recurrent myocardial infarction

Mesh:

Year:  2020        PMID: 32130926      PMCID: PMC7254576          DOI: 10.1016/j.jacc.2019.12.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Circulating lymphocyte trafficking to the bone marrow contributes to lymphopenia in myocardial infarction.

Authors:  Yonggang Ma; Xiaoyuan Yang; Nuria Villalba; Victor Chatterjee; Amanda Reynolds; Sam Spence; Mack H Wu; Sarah Y Yuan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

Review 2.  Guidelines for in vivo mouse models of myocardial infarction.

Authors:  Merry L Lindsey; Keith R Brunt; Jonathan A Kirk; Petra Kleinbongard; John W Calvert; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Dominic P Del Re; Nikolaos G Frangogiannis; Stefan Frantz; Richard J Gumina; Ganesh V Halade; Steven P Jones; Rebecca H Ritchie; Francis G Spinale; Edward B Thorp; Crystal M Ripplinger; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 5.125

3.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 4.  Neuronal regulation of bone marrow stem cell niches.

Authors:  Claire Fielding; Simón Méndez-Ferrer
Journal:  F1000Res       Date:  2020-06-16

Review 5.  Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction.

Authors:  Stephanie W Tobin; Faisal J Alibhai; Richard D Weisel; Ren-Ke Li
Journal:  Cells       Date:  2020-08-13       Impact factor: 6.600

6.  Urea-based amino sugar agent clears murine liver and preserves protein fluorescence and lipophilic dyes.

Authors:  Michelle Hough; Michael Fenlon; Alison Glazier; Celia Short; Gerardo Esteban Fernandez; Jiabo Xu; Elaa Mahdi; Kinji Asahina; Kasper S Wang
Journal:  Biotechniques       Date:  2021-01-20       Impact factor: 1.993

Review 7.  Trained Immunity and Cardiometabolic Disease: The Role of Bone Marrow.

Authors:  Ioannis Mitroulis; George Hajishengallis; Triantafyllos Chavakis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-19       Impact factor: 8.311

8.  Reperfused vs. nonreperfused myocardial infarction: when to use which model.

Authors:  Merry L Lindsey; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Nikolaos G Frangogiannis; Ganesh V Halade; Caitlin C O'Meara; Francis G Spinale; Zamaneh Kassiri; Jonathan A Kirk; Petra Kleinbongard; Crystal M Ripplinger; Keith R Brunt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-11       Impact factor: 5.125

9.  ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure.

Authors:  Wolf-Stephan Rudi; Michael Molitor; Venkata Garlapati; Stefanie Finger; Johannes Wild; Thomas Münzel; Susanne H Karbach; Philip Wenzel
Journal:  Antioxidants (Basel)       Date:  2021-03-05

Review 10.  A new classification of cardio-oncology syndromes.

Authors:  Rudolf A de Boer; Joseph Pierre Aboumsallem; Valentina Bracun; Douglas Leedy; Richard Cheng; Sahishnu Patel; David Rayan; Svetlana Zaharova; Jennifer Rymer; Jennifer M Kwan; Joshua Levenson; Claudio Ronco; Paaladinesh Thavendiranathan; Sherry-Ann Brown
Journal:  Cardiooncology       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.